Clinics in California

By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified Sep 22, 2026

What California law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

California at a glance

Pharmacy regulator: California State Board of Pharmacy
503A framework: Follows the federal 503A framework
Telehealth prescribing: Regulatory: Telehealth allowed
Asynchronous prescribing: Regulatory: Async allowed
Compounded GLP-1 access: Regulatory: Compounded GLP-1 limited

Verified clinics serving California

No verified clinics serving California are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in California

Yes. A California resident can obtain FDA approved peptides such as semaglutide and tirzepatide by prescription from a California-licensed prescriber, including by asynchronous telehealth: Business and Professions Code section 2242 says an appropriate prior exam does not require a synchronous interaction and can be done through a questionnaire if the standard of care is met. Compounded peptides are harder to get in California than in most states, because the California State Board of Pharmacy's rewritten compounding regulations (16 CCR 1735 and 1736 series, 2025) define "essentially a copy" more strictly than federal law, and any out-of-state pharmacy shipping sterile compounded injectables into California needs both a nonresident pharmacy license and a nonresident sterile compounding license. [1] [2] [3] [4] [5] [6] [7] [8] [9] [11] [12]

Compounded GLP-1 access in California

Branded Wegovy, Zepbound, Ozempic, and Mounjaro are available from California pharmacies, and California's asynchronous telehealth rules make branded prescriptions easy to obtain remotely. Compounded semaglutide and tirzepatide are more restricted in California than federal law alone requires: beyond the end of the FDA shortage allowances in 2025, California pharmacists must document a clinically significant difference for the individual patient before compounding a GLP-1 that matches a commercial product, and a lower price is not a qualifying reason. The Board's rules allow shortage-based compounding again only if the drug returns to the FDA or ASHP shortage list. [3] [7] [15]

Research use only sellers in California

California's Sherman Food, Drug, and Cosmetic Law bars selling, delivering, or giving away any new drug in California unless it has federal approval or a California approval (Health and Safety Code section 111550). "Research use only" peptides sold for human use are unapproved new drugs under both the Sherman Law and federal law, and only licensed pharmacies may dispense prescription drugs to California patients. [10] [16]

California notes on specific peptides

Semaglutide: Available branded by prescription, including after an asynchronous questionnaire-based telehealth exam under Business and Professions Code section 2242. Compounded semaglutide requires a documented clinically significant difference for the patient under California's 2025 essentially-a-copy rules, a stricter bar than the federal patient-specific exception. [3] [7] [15]
Tirzepatide: Available branded by prescription. Compounded tirzepatide faces the same California clinically significant difference requirement, and any compounded vial shipped from outside California must come from a pharmacy holding a nonresident sterile compounding license under section 4127.2. [3] [9]
BPC-157: Not FDA approved and not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk; a state board cannot authorize what federal law does not. California pharmacies apply the federal bulks test plus the Board's rewritten compounding standards, and the Board has not issued a BPC-157 specific rule. [2] [13] [14]

How to check a clinic in California

Confirm the prescribing clinician's license with the California medical or nursing board.
Ask which pharmacy compounds or dispenses the peptide and check it in the California State Board of Pharmacy license lookup. [1] [2] [3] [4] [5] [8] [9] [12]
Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in California. [10] [16]

Common questions in California

Can I get a GLP-1 prescription in California through an online questionnaire?

Yes, if the prescriber meets the standard of care. California Business and Professions Code section 2242 says an appropriate prior exam does not require a synchronous interaction and can be done through telehealth, including a self-screening tool or questionnaire. The prescriber must be California-licensed and must document your consent to telehealth under section 2290.5. [6] [7]

All peptide legal questions for California